The Evolving Landscape of Psoriatic Arthritis
- PMID: 40681289
- DOI: 10.1016/j.rdc.2025.05.011
The Evolving Landscape of Psoriatic Arthritis
Conflict of interest statement
Disclosures A. Ogdie discloses consulting/advisory boards for the following: AbbVie, Amgen, BMS, Celgene, CorEvitas, Gilead, GSK, Johnson & Johnson, Eli Lilly, Novartis, Pfizer, Spyre, Takeda, UCB; grants from the following: AbbVie to Penn, Pfizer to Penn, Novartis to Penn, Amgen to Forward/NDB, J&J to Penn, UCB to Penn; NIAMS, Rheumatology Research Foundation, and National Psoriasis Foundation. E. Ruderman discloses consulting or advisory work for the following: AbbVie, Amgen, BMS, Janssen, Lilly, Merck, Novartis, NS Pharma, and UCB.
References
Publication types
LinkOut - more resources
Full Text Sources